Insights Into The Global Oligonucleotide Therapy Market 2022-2031 Forecast Period

The Business Research Company's Oligonucleotide Therapy Global Market Report 2022 – Market Size, Trends, And Global Forecast 2022-2026

LONDON, GREATER LONDON, UK, October 19, 2022 /EINPresswire.com/ -- As per The Business Research Company's "Oligonucleotide Therapy Global Market Report 2022”, the oligonucleotide therapy market share is predicted to grow from $0.98 billion in 2021 to $1.10 billion in 2022 at a compound annual growth rate (CAGR) of 12.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, affecting many markets across the globe. The oligonucleotide therapy global market is expected to reach $1.86 billion in 2026 at a CAGR of 14.0%. The rise in the number of cancer cases across the globe is likely to contribute to the growth of the oligonucleotide therapy market during the forecast period.

Request A Sample Now To Gain A Better Understanding Of Oligonucleotide Therapy Market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3398&type=smp

Key Trends In The Oligonucleotide Therapy Market
The developers and providers of the oligonucleotide therapy global market are investing in oligonucleotide therapy market research and development to remodel the design of therapy to reduce its side effects on patients. The new and innovative oligonucleotides allow precision medicine approaches and can be designed to selectively target any gene with minimal side effects. It also helps in targeting patient-specific sequences that are causative of rare diseases. In August 2020, FDA granted accelerated approval to Viltepso (viltolarsen) injection, an antisense oligonucleotide for the treatment of Duchenne muscular dystrophy (DMD), which is a genetic disorder, with reduced side effects.

Overview Of The Oligonucleotide Therapy Market
The oligonucleotide therapy market consists of sales of oligonucleotide therapy-related services by entities (organizations, sole traders, and partnerships) that manufacture oligonucleotide therapy products. Oligonucleotide therapy uses synthetic oligonucleotides, which can be artificially produced in labs, to inactivate disease-causing genes. Only goods and services traded between entities or sold to end consumers are included.

Learn More On The Global Oligonucleotide Therapy Market Report At:
https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report

Oligonucleotide Therapy Global Market Report 2022 from TBRC covers the following information:

Market Size Data
Forecast period: Historical and Future
By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Market Segmentation
By Type: Antisense Oligonucleotide, Aptamer, Others
By Application: Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others
By End User: Hospitals, Research Institutes.
By Geography: The global oligonucleotide therapy market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.

Major market players such as Alnylam Pharmaceuticals Inc., Biogen Inc., Dynavax Technologies Corp., Ionis Pharmaceuticals Inc., Merck & Co. Inc., Miragen Therapeutics Inc., PCI Biotech Holdings ASA, Sarepta Therapeutics Inc., Jazz Pharmaceuticals and Bausch & Lomb.

Trends, Opportunities, Strategies And So Much More.
Oligonucleotide Therapy Global Market Report 2022 is one of The Business Research Company’s comprehensive reports that provides an oligonucleotide therapy market forecast analyzes oligonucleotide therapy global market size, oligonucleotide therapy market growth drivers, oligonucleotide therapy market segments, oligonucleotide therapy global market major players, oligonucleotide therapy global market growth across geographies, and oligonucleotide therapy global market competitors’ revenues and market positioning. The oligonucleotide therapy global market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.

Not What You Were Looking For? Go Through Similar Reports By The Business Research Company:

Gene Editing Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/gene-editing-global-market-report

Molecular Diagnostics Devices And Equipment Global Market Report 2022
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-devices-and-equipment-global-market-report

Nucleic Acid Based Gene Therapy Market 2022
https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market

About The Business Research Company?
The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Get in touch with us -
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Check out our:
TBRC Blog: http://blog.tbrc.info/
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Healthcare Blog: https://healthcareresearchreports.com/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Market Research Products, Services, Solutions For Your Business - TBRC